Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid Biopsy

SIMPLE SUMMARY: Immunotherapy is emerging as an improved systemic treatment for select patients with advanced unresectable hepatocellular carcinoma. An objective response is reported in 30% of patients, yet a complete response allowing for curative-intent surgery is rare. Locoregional therapies seem...

Descripción completa

Detalles Bibliográficos
Autores principales: Raj, Roma, Wehrle, Chase J., Aykun, Nihal, Stitzel, Henry, Ma, Wen Wee, Krishnamurthi, Smitha, Estfan, Bassam, Kamath, Suneel, Kwon, David C. H., Aucejo, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650763/
https://www.ncbi.nlm.nih.gov/pubmed/37958394
http://dx.doi.org/10.3390/cancers15215220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650763/
https://www.ncbi.nlm.nih.gov/pubmed/37958394
http://dx.doi.org/10.3390/cancers15215220

Ejemplares similares